Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥504.02 Million ≈ $73.75 Million USD) by net assets (CN¥9.15 Billion ≈ $1.34 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chengdu Kanghong Pharmaceuticals Group C defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Chengdu Kanghong Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Chengdu Kanghong Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chengdu Kanghong Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghong Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Data Patterns (India) Limited NSE:DATAPATTNS	-0.032x
Servyou Software Group Co Ltd SHG:603171	0.030x
ATS Corporation NYSE:ATS	0.064x
Anhui Expressway Co Ltd SHG:600012	0.072x
California Water Service Group NYSE:CWT	0.098x
Bangkok Expressway and Metro Public Company Limited BK:BEM	-0.168x
Bravida Holding AB ST:BRAV	0.037x
Olin Corporation NYSE:OLN	0.160x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 002773 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.27 Billion ≈ $1.36 Billion	CN¥1.50 Billion ≈ $220.03 Million	0.162x	-0.71%
2024-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥1.41 Billion ≈ $206.60 Million	0.163x	+4.69%
2023-12-31	CN¥7.81 Billion ≈ $1.14 Billion	CN¥1.22 Billion ≈ $178.29 Million	0.156x	+16.44%
2022-12-31	CN¥6.91 Billion ≈ $1.01 Billion	CN¥925.15 Million ≈ $135.38 Million	0.134x	+65.50%
2021-12-31	CN¥6.10 Billion ≈ $893.35 Million	CN¥494.11 Million ≈ $72.30 Million	0.081x	+70.45%
2020-12-31	CN¥5.76 Billion ≈ $842.26 Million	CN¥273.32 Million ≈ $39.99 Million	0.047x	-72.98%
2019-12-31	CN¥4.62 Billion ≈ $676.13 Million	CN¥812.15 Million ≈ $118.84 Million	0.176x	+104.58%
2018-12-31	CN¥4.08 Billion ≈ $597.61 Million	CN¥350.88 Million ≈ $51.35 Million	0.086x	-60.30%
2017-12-31	CN¥3.54 Billion ≈ $518.52 Million	CN¥766.86 Million ≈ $112.22 Million	0.216x	-25.72%
2016-12-31	CN¥2.90 Billion ≈ $425.08 Million	CN¥846.35 Million ≈ $123.85 Million	0.291x	+52.64%
2015-12-31	CN¥2.52 Billion ≈ $369.49 Million	CN¥481.97 Million ≈ $70.53 Million	0.191x	+5.59%
2014-12-31	CN¥1.61 Billion ≈ $235.85 Million	CN¥291.38 Million ≈ $42.64 Million	0.181x	-24.65%
2013-12-31	CN¥1.39 Billion ≈ $203.30 Million	CN¥333.31 Million ≈ $48.77 Million	0.240x	-5.84%
2012-12-31	CN¥1.11 Billion ≈ $161.87 Million	CN¥281.84 Million ≈ $41.24 Million	0.255x	+41.29%
2011-12-31	CN¥936.39 Million ≈ $137.02 Million	CN¥168.86 Million ≈ $24.71 Million	0.180x	-17.63%
2010-12-31	CN¥624.85 Million ≈ $91.44 Million	CN¥136.79 Million ≈ $20.02 Million	0.219x	+8.98%
2009-12-31	CN¥539.75 Million ≈ $78.98 Million	CN¥108.42 Million ≈ $15.87 Million	0.201x	--

About Chengdu Kanghong Pharmaceuticals Group Co Ltd

SHE:002773 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.71 Billion

CN¥18.52 Billion CNY

Market Cap Rank

#5339 Global

#1024 in China

Share Price

CN¥20.10

Change (1 day)

-2.28%

52-Week Range

CN¥19.91 - CN¥46.13

All Time High

CN¥52.89